These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Recovery from anthracycline cardiomyopathy--how can it be explained? Christiansen S J Heart Lung Transplant; 2009 Jul; 28(7):751. PubMed ID: 19560709 [No Abstract] [Full Text] [Related]
7. Anthracycline-induced cardiomyopathy in children: a report of six cases. Dearth J; Osborn R; Wilson E; Kelly D; Mantle J; Rogers E; Malluh A; Crist W Med Pediatr Oncol; 1984; 12(1):54-8. PubMed ID: 6583470 [TBL] [Abstract][Full Text] [Related]
15. Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy. Torti FM; Bristow MM; Lum BL; Carter SK; Howes AE; Aston DA; Brown BW; Hannigan JF; Meyers FJ; Mitchell EP Cancer Res; 1986 Jul; 46(7):3722-7. PubMed ID: 3458531 [TBL] [Abstract][Full Text] [Related]
16. Expectations and limitations of endomyocardial biopsy. Mills AS; Hastillo A; Thompson JA; Hess ML Can J Cardiol; 1985; 1(6):358-62. PubMed ID: 3915878 [TBL] [Abstract][Full Text] [Related]